These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16000865)

  • 1. Transfection of Mülller cells with type I interferon transgenes: resistance to HSV-1 infection.
    John-Philip B; Carr DJ
    Methods Mol Med; 2005; 116():221-32. PubMed ID: 16000865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection.
    Härle P; Cull V; Guo L; Papin J; Lawson C; Carr DJ
    Antiviral Res; 2002 Oct; 56(1):39-49. PubMed ID: 12323398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
    Rautsi O; Lehmusvaara S; Salonen T; Häkkinen K; Sillanpää M; Hakkarainen T; Heikkinen S; Vähäkangas E; Ylä-Herttuala S; Hinkkanen A; Julkunen I; Wahlfors J; Pellinen R
    J Gene Med; 2007 Feb; 9(2):122-35. PubMed ID: 17191255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2.
    Härle P; Lauret E; Pitha PM; De Maeyer E; Carr DJ
    Virology; 2001 Nov; 290(2):237-48. PubMed ID: 11883188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.
    Härle P; Cull V; Agbaga MP; Silverman R; Williams BR; James C; Carr DJ
    J Virol; 2002 Jul; 76(13):6558-67. PubMed ID: 12050368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo.
    Cui B; Carr DJ
    J Neuroimmunol; 2000 Aug; 108(1-2):92-102. PubMed ID: 10900342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
    Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
    Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon mediated antiviral activity against salmonid fish viruses in BF-2 and other cell lines.
    Saint-Jean SR; Pérez-Prieto SI
    Vet Immunol Immunopathol; 2006 Mar; 110(1-2):1-10. PubMed ID: 16169598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
    Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P
    Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
    Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
    J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG; Krisky DM; Ataai MM; Glorioso JC
    Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious salmon anemia virus is a powerful inducer of key genes of the type I interferon system of Atlantic salmon, but is not inhibited by interferon.
    Kileng Ø; Brundtland MI; Robertsen B
    Fish Shellfish Immunol; 2007 Aug; 23(2):378-89. PubMed ID: 17257858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation.
    Holland JW; Bird S; Williamson B; Woudstra C; Mustafa A; Wang T; Zou J; Blaney SC; Collet B; Secombes CJ
    Mol Immunol; 2008 Dec; 46(2):269-85. PubMed ID: 18805586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice.
    Jamali A; Bamdad T; Soleimanjahi H; Pakdel FG; Arefian E
    Neuroimmunomodulation; 2007; 14(1):16-23. PubMed ID: 17700036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.
    Barreca C; O'Hare P
    J Virol; 2006 Sep; 80(18):9171-80. PubMed ID: 16940528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.
    Griffith C; Noonan S; Lou E; Shillitoe EJ
    Cancer Gene Ther; 2007 Dec; 14(12):985-93. PubMed ID: 17853922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.
    Konopka K; Fallah B; Monzon-Duller J; Overlid N; Düzgünes N
    Cell Mol Biol Lett; 2005; 10(3):455-70. PubMed ID: 16217556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.